Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pharmacotherapy with benzodiazepines: basic principles and new developments]

H Möhler1

  • 1Institut für Pharmakologie, Universität und ETH Zürich.

Praxis
|April 9, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The immunohistochemical distribution of the GABA<sub>A</sub> receptor α<sub>1</sub>, α<sub>2</sub>, α<sub>3</sub>, β<sub>2/3</sub> and γ<sub>2</sub> subunits in the human thalamus.

Journal of chemical neuroanatomy·2017
Same author

Photometry, colorimetry, nephelometry.

Chimia·2010
Same author

Absorption spectrophotometric studies of sunscreens.

Chimia·2010
Same author

Differential localization of gamma-aminobutyric acid type A and glycine receptor subunits and gephyrin in the human pons, medulla oblongata and uppermost cervical segment of the spinal cord: an immunohistochemical study.

The Journal of comparative neurology·2009
Same author

Transgenic and targeted mutant mice in drug discovery.

Current opinion in drug discovery & development·2009
Same author

Altered mnemonic functions and resistance to N-METHYL-d-Aspartate receptor antagonism by forebrain conditional knockout of glycine transporter 1.

Neuroscience·2009
Same journal

Praxis·2026
Same journal

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026
Same journal

[Laser interstitial thermotherapy (LITT): a minimally invasive neurosurgical treatment option for brain tumours and radiation necrosis].

Praxis·2026
Same journal

[Persistent back pain after lifting trauma. From the trivial to the rare case].

Praxis·2026
Same journal

[A patient with dizziness and gait instability - a diagnostic challenge].

Praxis·2026
Same journal

[Meningoencephalitis caused by listeria monocytogenes].

Praxis·2026
See all related articles

Benzodiazepines enhance GABA effects for neurologic and psychiatric disorders. Future treatments aim for receptor subtype selectivity to minimize side effects.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Context:

  • GABAergic neurotransmission is crucial for managing neurologic and psychiatric conditions.
  • Benzodiazepines modulate GABAA receptors, influencing CNS activity.
  • Current pharmacotherapy relies on amplifying inhibitory neurotransmitter effects.

Purpose:

  • To explore novel ligands for benzodiazepine receptors.
  • To achieve selective activity profiles with reduced side effects.
  • To advance therapeutic strategies for CNS disorders.

Summary:

  • Pharmacotherapy for CNS disorders often involves enhancing GABAergic signaling.
  • Benzodiazepines are key modulators of GABAA receptors, exhibiting activity-dependent effects.
  • Developing subtype-selective ligands and partial agonists is a promising avenue for improved treatments.

Related Experiment Videos

Impact:

  • Potential for more targeted and safer treatments for neurologic and psychiatric conditions.
  • Advances in understanding GABAA receptor pharmacology.
  • Improved patient outcomes through minimized side effects.